
![]() |
The Future of Personalized Health: 23andMe
Anne has built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. Anne joined us last year for 3 CEOs, but this time she’s back to talk about how 23andMe and their most recent acquisition, CureTogether, can empower consumers by giving them access to their genetic information and crowd-sourced treatment reviews.

![]() |
The Future of Personalized Health
The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?

![]() |
Interview with Anne Wojcicki
We talked with Anne Wojcicki, CEO at 23andme, about the biggest challenges, trends and developments in health care technology at the Health 2.0 San Francisco 2011 Fall Conference.

![]() |
Anne Wojcicki @ 3 CEOs

![]() |
In Conversation with 3 CEOs
Here we hear 3 CEOs of companies transforming, and being transformed by, Health 2.0 in conversations about the future of their businesses. Anne Wojcicki is the Co-Founder and CEO, 23andme, is interviewed by Russ Mitchell of Kaiser Health News. West Shell, Chairman and CEO of Healthline, is interviewed by Zina Moukheiber of Forbes. Sona Mehring, Founder and CEO of CaringBridge, is interviewed by Chris Rauber of San Francisco Business Times.